Logo image of OSRH

OSR HOLDINGS INC (OSRH) Stock Fundamental Analysis

USA - NASDAQ:OSRH - US68840D1028 - Common Stock

0.7564 USD
+0.04 (+4.87%)
Last: 9/19/2025, 8:00:02 PM
0.7355 USD
-0.02 (-2.76%)
After Hours: 9/19/2025, 8:00:02 PM
Fundamental Rating

1

OSRH gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 538 industry peers in the Biotechnology industry. OSRH has a bad profitability rating. Also its financial health evaluation is rather negative. OSRH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year OSRH has reported negative net income.
In the past year OSRH has reported a negative cash flow from operations.
OSRH had negative earnings in 4 of the past 5 years.
In the past 5 years OSRH always reported negative operating cash flow.
OSRH Yearly Net Income VS EBIT VS OCF VS FCFOSRH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -1M -2M -3M

1.2 Ratios

The Return On Assets of OSRH (-7.18%) is better than 86.06% of its industry peers.
With an excellent Return On Equity value of -15.91%, OSRH belongs to the best of the industry, outperforming 87.36% of the companies in the same industry.
Industry RankSector Rank
ROA -7.18%
ROE -15.91%
ROIC N/A
ROA(3y)-1.18%
ROA(5y)-1.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OSRH Yearly ROA, ROE, ROICOSRH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 20 40 60 80

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for OSRH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OSRH Yearly Profit, Operating, Gross MarginsOSRH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for OSRH has been reduced compared to 1 year ago.
Compared to 1 year ago, OSRH has a worse debt to assets ratio.
OSRH Yearly Shares OutstandingOSRH Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M
OSRH Yearly Total Debt VS Total AssetsOSRH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

OSRH has an Altman-Z score of -0.40. This is a bad value and indicates that OSRH is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.40, OSRH perfoms like the industry average, outperforming 58.92% of the companies in the same industry.
OSRH has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
OSRH's Debt to Equity ratio of 0.05 is on the low side compared to the rest of the industry. OSRH is outperformed by 60.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z -0.4
ROIC/WACCN/A
WACCN/A
OSRH Yearly LT Debt VS Equity VS FCFOSRH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

OSRH has a Current Ratio of 0.18. This is a bad value and indicates that OSRH is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of OSRH (0.18) is worse than 95.91% of its industry peers.
A Quick Ratio of 0.17 indicates that OSRH may have some problems paying its short term obligations.
With a Quick ratio value of 0.17, OSRH is not doing good in the industry: 95.72% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.18
Quick Ratio 0.17
OSRH Yearly Current Assets VS Current LiabilitesOSRH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1M 2M 3M

More info and screens

1

3. Growth

3.1 Past

OSRH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -298.80%.
Looking at the last year, OSRH shows a very strong growth in Revenue. The Revenue has grown by 115.11%.
EPS 1Y (TTM)-298.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.88%
Revenue 1Y (TTM)115.11%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%28.77%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

OSRH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OSRH Price Earnings VS Forward Price EarningsOSRH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OSRH Per share dataOSRH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

OSRH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OSR HOLDINGS INC

NASDAQ:OSRH (9/19/2025, 8:00:02 PM)

After market: 0.7355 -0.02 (-2.76%)

0.7564

+0.04 (+4.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.35%
Inst Owner Change39.74%
Ins Owners0.21%
Ins Owner Change0%
Market Cap16.33M
AnalystsN/A
Price TargetN/A
Short Float %5.33%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.61
P/FCF N/A
P/OCF N/A
P/B 0.2
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.69
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.09
BVpS3.88
TBVpS-4.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.18%
ROE -15.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1.18%
ROA(5y)-1.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.18
Quick Ratio 0.17
Altman-Z -0.4
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-298.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.88%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)115.11%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%28.77%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-117.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-228%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-227.31%
OCF growth 3YN/A
OCF growth 5YN/A